Show simple item record

dc.contributor.advisorIsoherranen, Nina
dc.contributor.authorAmory, John Kenneth
dc.date.accessioned2017-10-26T20:53:16Z
dc.date.submitted2017-06
dc.identifier.otherAmory_washington_0250O_17526.pdf
dc.identifier.urihttp://hdl.handle.net/1773/40669
dc.descriptionThesis (Master's)--University of Washington, 2017-06
dc.description.abstractUniversity of Washington Abstract Isotretinoin Administration Improves Sperm Production in Men with Infertility John K. Amory MD, MPH Chair of the Supervisory Committee: Dr. Nina Isoherranen, Associate Professor Department of Pharmaceutics Objective: There is currently no effective medical therapy for men with infertility due to oligoasthenozoospermia (OA). As men with OA have lower concentrations of 13-cis-retinoic acid in their testes, we hypothesized that men with infertility from OA might have improved sperm counts when treated with isotretinoin (13-cis-retinoic acid). Design and Setting: We conducted a single-site, single-arm, pilot study to determine the impact of therapy with isotretinoin on sperm indices in 19 infertile men with OA. Subjects: Subjects were men between 21 and 60 years of age with infertility of more than 12 months associated with sperm concentrations below 15 million sperm/ml. Intervention: All men received isotretinoin 20 mg by mouth twice daily for 20 weeks. Outcome Measures: Subjects had semen analyses, physical examinations, routine blood counts, and chemistries every four weeks during treatment. Results: Nineteen men enrolled in the study. Median (25th, 75th) sperm concentration increased from 2.5 (0.1, 5.9) million/ml at baseline to 3.8 (2.1, 13.0) million/ml at the end of treatment (p=0.006). No significant changes in sperm motility were observed. There was a trend towards improved sperm morphology (p=0.056). Six pregnancies (three spontaneous and three from ICSI) and five births occurred during the study. Four of the births, including all three of the spontaneous pregnancies, were observed in men with improvements in sperm counts with isotretinoin therapy. Conclusions: Isotretinoin therapy of men with OA is associated with improvements in sperm production. Additional studies of isotretinoin therapy for men with infertility from OA are warranted.
dc.format.mimetypeapplication/pdf
dc.language.isoen_US
dc.rightsnone
dc.subjectMale infertility
dc.subjectretinoic acid
dc.subjectspermatogenesis
dc.subjectPharmaceutical sciences
dc.subject.otherPharmaceutics
dc.titleIsotretinoin Administration Improves Sperm Production in Men with Infertility
dc.typeThesis
dc.embargo.termsRestrict to UW for 1 year -- then make Open Access
dc.embargo.lift2018-10-26T20:53:16Z


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record